A mouse liver eDNA library in "-ZAP was screened using a 627 bp portion of 32p randomly labeled human dihydropteridine reductase (731 bp) cDNA and seven positive clones were obtained. Six of these clones were sequenced using T3 and T7 primers as well as five selected 18 -mer oligonucleotides in a "primer walking" strategy. From the data a consensus sequence was obtained for the coding region, the 5 ' flanking region and the 3' flanking region up to the poly-A tail. Of the 720 nucleotides in the coding region of mouse dihydropteridine reductase only 89 were different from those in the human reductase and only 31 nucleotides were different from those in the rat reductase. The amino acid sequence of the mouse reductase on the other hand differed from that of the human reductase by 15 residues in addition to the three extra alanine residues at positions 4, 5 and 6 from the N terminus; and from the rat reductase by 6 residues, many of which were conservative changes. The rat enzyme differed from the human enzyme in 9 residues in addition to the three alanines. The similarity of the eDNA coding regions and the reductases produced were characteristic of, and essential for, a "house-keeping" enzyme. The DNA in the 5 ' and 3' flanking regions of the three cDNAs, on the other hand, were very dissimilar although the human DNA had diverged a lot more from the mouse DNA than the rat DNA. Initiation, termination and poly-A tail consensus sequence signals were identified in all three cDNAs. A vector was engineered that expressed mouse dihydropteridine reductase which had kinetic parameters (Km for q-6MeDHP 17.411M, NADH 7.311M and k 170 sec\ and Km for natural q-6R-BH 2 8 .711M, NADH 7.711M and k 44.3 sec l ) similar to those for the natural mouse reductase (Km for q-6MeDHP 16.5 llM, NADH 16.0 llM and k 214 secl; and Km for natural q-6R-BH2 4.7 llM, NADH 9 .111M and k 81.9 sec l ) which was purified from mouse liver.
sequence which codes for the reductase of human liver has been determined simultaneously by Cotton and Dahl's group (5) and by Ledley, Woo and Kaufman 's groups (6) in 1987. At the end of the same year Whiteley and coworkers (7 ) determined the cDNA sequence of dihydropteridine reductase from rat liver. The cDNA sequences reported included the 5 '-flanking sequences upstream of the A TG start codon (open reading frame) as well as the 3'-flanking regions downstream of the stop codons TAG (for human ) and TAA (for rat) up to the poly-A tails. We now report the sequence of a cDNA clone of dihydropteridine reductase derived from a mouse liver cDNA library. This is required for screening a mouse genomic library in order to prepare a mouse in which the reductase is "knocked out", i.e. a mouse model of the metabolic disease phenylketonuria due to dihydropteridine reductase deficiency. These data also provide us with the opportunity to compare the DNA sequences not only of the coding regions but also the 5' and 3' flanking sequences of the coding regi ons of human, rat and mouse cDNAs.
Materials and Methods
Restriction enzymes and related buffers were purchased from Pharmacia and Progen Co, radiolabeled 3Z p dA TP was from Amersham and Agarose (Bio-Rad) was DNA grade. 2 x YT m edium contains BACTO tryptone (16 g , DIFC O Laboratories), BACTO yeast extract (10 g, DIFCO Laboratories) and NaCl (5 g) in H zO ( I L). DNA sequencing reactions were carried out by using dye -primers or dye-terminators in a Corbett Research Thermal Cycler FTS 4000, run on a gel and scanned through a DNA Applied Biosystems (Model 373 A) Autosequencer. The data were evaluated using Sequence Editor 675 (Vl.0 .0), MacVector 4.1.4. and MacVector AssemblyLIGN programs. Kinetic measurements were made on a Cary 219 double beam spectrophotometer using cuvettes thermostated at 25" and with 1 cm path lengths.
cDNA probe preparation
Human dihydropteridine reductase cDNA cloned into Bluescript (kindly supplied by Dr H.-M . H. Dahl, The Murdoch Institute, Melbourne, Australia, and used by us previously, 8 ) was digested with EcoRI, and the 627bp fragment (containing 6I3bps from the ATG start codon up to the first EcoRI site of the 731 bps of the dihydropteridine reductase cDNA) was isolated from an agarose gel. This DNA was randomly labeled with a _ 3Z p dATP in the presence of random decanucleotide primers (from Bresatec) (9 ) . The labeled DNA probe was precipitated with ethanol and dissolved in TE buffer and kept on ice until required.
Screening the mouse cDNA library
A AZAP vector containing the mouse liver cDNA library (Stratagene ) was used to infect bacteria which were grown on Agarose LB plates and screened with the above radiolabeled DNA probe from human DHPR cDNA. The phages containing the inserts were plated out to a density of ca 10,000 pfu per 90 mm petri dish . Plaques were transferred onto H ybond N+ membrane s (Amersham) (10) and hvbridised according to Amersham's procedure . A total of forty positiye clones \\·ere identified (as obsern:d on J photographic film ) I 10 1 in the first screen . The third screen prmided a total of seyen purified clones. The AZAP yecto r, in the presence of Ex.-\ssist helper phage , allows in vitro rapid excision of the Bluescript SK( -) phagemid which contains th e cDNA inserts (11). proAB lacr ZL1M15] SuO (non-suppressing) cells in LB broth and plated on LB-Amp ( 50 )..I.g/ ml ) agar plates. These colonies now contain pBluescript double stranded phagemid with the cloned DNA insert (for details of procedures see Stratagene instruction manual ). The sizes of the inserts were determined by restriction enzyme digestion of the phagemids with Eco RI , running the DNA on agarose gels and \-isuali sing the bands with ethidium bromide. Of the se\en clones that were isolated five had ca 1 .2 -1 . .3 Kb inserts, one a ca 2.0 Kb insert and thc l.1st (\ l'C was cut at three sites yiel ding 1.0 and OS -: k :- DNA fragments ( Figure 1 ). The latter clone was discarded.
cDNA sequencing
The above clones were prepared for sequencing using the Applied Biosystems plasmid prep protocol. The pBluescript DNA was transformed into XLI Blue cells MRF-(grown in LB-Amp 50 J..lg/ :-ml broth) and the DNA was prepared by alkaline lysis (NaOH/SDS) followed by three extractions with CHCI 3 and precipitation with 13% po-. . -Iyethylene glycol solution. DNA sequencing was carried out using a Taq d ye primer cycle sequencing kit. The kit uses --T3 and T7 primers so that the insert can be sequenced from both 5 ' and 3' ends. Sequencing data were also obtained using the PRISM Ready Reaction Dyedeoxy Terminator Cycle Sequencing Kit. Four clones were sequenced from the 3 ' end of the insert cDNA and contained the poly-A segment. These gave data correct to ca 300 bases identifYing the sequence end adjacent to the poly -A tail of the cDNA. Six clones were sequenced from the 5' end. A consensus sequence from the 5 ' end of the insert was obtained from all the clones, although the most useful information came from three clones (clones 1, 2 and 3, Figure 1 ) which had the full length of cDNA. The consensus sequence was used to select three oligonucleotides for further sequencing in a "primer walking" strategy. Three other clones examined (clones 4, 5
Pteridines/Vol. 7 / No. 1 and 6) were compared with the others, and were found to be truncated at the 5 ' end with loss of 25, 31 and 40 bps of the coding region ( Figure  1 ). Three oligonucleotide primers 5 ' -ATT-CATTCACAGAGCAGGC-3' (primer I ), 5 '-AC -TATCTCCAGCACTTGGC-3' (primer II ) and 5'-ACTCAGGAAGCCTAATCC-3' (primer III ) were synthesised and provided sequences (i n the 3 ' direction) from base numbers 251, 425 and 746 towards the 3' end of the insert (Figure 2 ). These data gave the full length sequence of the cDNA including the 5' flanking sequence. In order to obtain the complete sequence of the 3 ' flanking region the oligonucleotide 5 '-GGCA -GTTAATTTTCAGGC-3' (primer IV, 135 bases from the poly-A tail) was synthesised and used to sequence in the 5' -direction away from the poly-A tail. Three clones (clones 1,2 and 3 ) possessed the full-length of the cDNA sequences but the seq uence of the longest insert (clone 1, ca 2 Kb) was different from the others at the region upstream but adjacent to the poly-A tail. A fifth I8-mer oligonucleotide pri~~;-:::-S '-CGC -TGCTGGCTTTATGCC-3' (primer V ) was synthesised and used to obtain the upstream sequence from the poly-A tail of this clone (see Figure ( 12 ) constructed from pGEX2T ( 13 ), (Glutageni, AMRAD Corporation) and containing the Sj 26 gene (which codes for Schistosoma japonica glutathione S-transferase GST ) ( 14) fused with the cDNA of human dihydropteridine reductase (hDHPR). Digestion of this plasmid DNA with the endonucleases Pst I , Bgl I, EcoR I and Apa I revealed that although the DNA sequence of the conjugated GSThDHPR cDNA was intact, the plasmid supplied was short by ca 800 bp in the region of the Tac promoter and the LacZ gene. Also the bacteria containing this plasmid did not induce the expression of the fusion protein (GST-hDHPR) when IPTG was added at the appropriate time . We therefore re-engineered the plasmid by digesting it with Sca I which cuts pDHPR-WR in the Sj26 gene near the ATG start codon and 1778 bp downstream of it but away from the hDHPR gene to give two DNA fragments, one containing the Sj 26 and hDHPR genes and the other con- Rot OHPRc TGAGGGT   1030  1040  1050  1060  1070  1080  1090  1100  1110  1120  1139  1140 1150 CCATGTIGGT   1160  1170  1180  1190  1200  12 10  1220  1230  1240  lZ50 1260 on Agarose gels and the desired DNA fragments A and D (see Scheme 1) were isolated using a silica matrix (15) . Fragments A (100 ng) and D (200 ng) (Scheme 1 ) were ligated with T4 DNA ligaseand the construct was transformed into competent JM 109 cells. The selected clones with the correct plasmid pGEX2T-mDHPR were identified by their size, by digestion with EcoR I and Asc I, and finally confirmed by partial sequencing using primers II and IV (above ) which indeed showed that the mouse DHPR eDNA was present in the plasmid.
Expression of mDHPR
A bacterial plaque (JMI09) containing pGEX 2T -mDHPR was used to inoculate 50 ml of 2 x YT medium (Amp, 100 ~g/ml) and grown overnight at 37". This was added to 950 ml of 2 x YT ( +2% glucose and Amp 100 ~g/ml) and incubated in an orbital shaker at 37" until the OD S95 reached 1 when 100 mM IPTG (1 ml) was added and incubation continued until the OD S9S reached 1.8. The cells were collected ( 4000 x g, 10 min, 4 "), suspended in MTPBS (25 ml), sonicated at 4" or 10 min (1 min bursts) and centrifuged at 17, 500 x g (10 min, 4°). The supernatant was further centrifuged at 113,500 x g (60 min, IS"), and the supernatant was stored at -20" until required. It had a total of 1752 units of DHPR activity and 124.5 units of GST activity. This was purified by percolating through a GS-Agarose column (8 ml, Sigma), washed with an equal volume of MTPBS and then washed with MTPBS (ca 500 ml) until the effluent was free from protein (Bio-Rad reagent). The bound GST-mDHPR fusion protein was eluted with 50 mM Tris-HCI (pH 8 .0) containing 5 mM reduced glutathione (2 x 34 ml ). These eluates were dialysed against MTPBS (3 x lL, overnight) at 4" and stored at _20" until required. The first eluate (34 ml) showed only a trace of cleaved protein (M r 28 k ) on SDS-PAGE and contained almost pure fusion protein (M r ca 52 k). It had a total of 544 units of DHPR activity (16 D / ml) and contained 0.42 mg/ml of fusion protein . This (32 ml ) was mixed with GSAgarose (2 ml) and rotated gently for 2 h at room temperature. It was then placed in a column and the flow-through (ca 30 ml) contained unbound fusion protein (81 DHPR units, 64 mg/ ml). The beads were then washed thoroughly free from protein with MTPBS and then placed in a tube containing MTPBS (2 ml ) and 100 NIH units of thrombin (human plasma, Sigma) and rotated gently for 2 h at room temperature. The mixture was placed again in a column and eluted with MTPBS. The combined flow-through and wash was dialysed against 50 mM Tris-HCl (pH 7.4) containing 2 mM DTT (3x lL) to give pure mDHPR [6 ml, total 113 DHPR units, IS.S U/ml, 0.25 mg/ ml]. Further treatment of the beads with thrombin (100 NIH U, 16 h at 25") gave only a further 2.9 DHPR units (5 ml).
Isolation of DHPR from mouse liver
Chopped livers (12 .5 g) from ten recently decaased mice (C57Bl/6 and BALB C, mixed sexcs;killed in a CO 2 atmosphere) were suspended in ice-cold 0.1 M Tris-HCI (pH S.6) and 0 .1 mM EDTA (25 ml) and run through 15 passes in a fast spinning Potter homogeniser at ca 4°. The homogenate was centrifuged at 27,000 x g for 45 min. The residue was re-suspended in the same buffer (10 ml ), re-homogenised and centrifuged. The combined supernatants " 'ere centrifuged again at 190,000 x g tor 1 h at 10". The clear supernatant (25 m ) contained 40 mg/ ml of total protein (Bio-Rad reagent ) and the total DHPR activity was 147.5 units (see below; 0.147 U/mg). The crude extract (10 mis, 59 U) after dialysis against 50 mM Tris-HCI buffer pH 7.4 containing 0.8 M NaCI and 0.1 mM NADH (3x 500 ml, 24 h) was purified using a naphthoquinone colunm (17 ml ) as described for the purification of the human enzyme ( 16) , and the active fractions were eluted with 50 mM Tris-HCI (pH 7.4) containing 4 mM DTT, concentrated by ultrafiltration in a stirrer cell with a PM 10 filter (Amicon, and 40 psi of N2), and the buffer replaced with 50 mM Tris-HCl (pH 7.4) containing 2 mM DTT. One ml of DHPR active solution' (32.6 U, 12.6 mg of protein) was obtained which gave one band on SDS-PAGE at M r 28 k (hDHPR was at 25.7 k ) as was observed with enzyme expressed in bacteria when compared with hDHPR.
Assays
The DHPR assay was performed as before (17) . For determining the Km and V (k) values the rates were measured for at least five different concentrations of tetrahydro-pterin (18) and natural 6R -5,6,7,S-tetrahydrobiopterin (S chirks Laboratories, Switzerland) and at least five different concentrations of NADH (i.e. at least 25 duplicate runs) and evaluating all the data together using a computer program (19) to provide two Km values and one V (k) value.
The GST assay (20) was performed by adding 1 M potassium phosphate buffer pH 6.5 containing O.IM EDTA (900 Ill ) and 20 mM reduced glutathione (50 Ill) to both cuvettes, the enzyme (5 -1 0 Ill) was added to the reaction cuvette and allowed to equilibrate at 25". 20 mM l-Chloro-2,4-dinitrobenzene in EtOH (20 Ill) was added to the reference cuvette and the reaction started by adding 20 III of this chlorodinitrobenzene solution to the reaction cuvette. The rate of the change of OD34{) is measured using the e value of 9,600 M '\cm'\ and a unit of GST activity is the amount of enzyme used to catalyse the reaction of one Ilmole of chloronitrobenzene/min under the above conditions.
Results and Discussion
cD~A libraries are constructed trom a gamut of mR~As trom a particular tissue taking adyantage of the poh" T tails that are characteristic of mR...'\'.-\s. Csing reyerse transcription, the cD~.-\ s corresponding to the mR...,,\,As in the library arc prepared. All the cD~As produced therefore ha\'e poly-A tails. When these are passed through a poly-T bound Agarose column, they are held to the column and all other RNA and DNA filter through. The cDNAs of the respective mRNAs are selectively isolated, and are engineered, using polylinker DNA, to have restriction sites (e.g. Eco Rl) at their ends with which they can be ligated into appropriate vectors (e.g. ",ZAP) and transformed into selected microorganisms . Because of the manner is which the library is constructed the cD N As possess all the 3 I -flanking sequences up to the po\y-A tails which provide the complete sequences of those portions of the cDNAs. However the 5 '-flanking regions are quite variable in length since they depend on where the mRNAs were cleaved or sheared. This has been realised in the present work. The complete mouse eDNA sequences of clone 1 ( 1,956 Kb) and clone 2 ( 1.297 Kb) have been determined and are displayed in Figure 2 .
The 5'-flanking regions
These regions for the human, rat and mouse DNA are compared in Figure 2 . When the 5 r flanking sequences were compared for the two human cDNAs reported we found that one sequence (5) was shorter than the other (6) by 56 bases and Pteridines/ Vol. 7 / No . I j itkred onl\' in the first base of the shorter sequence. Since these regions are different in lengths, comparisons from base number 38 of the mouse sequence (the start of the rat sequence reported), with the rat and human sequences were made. In this region the human and the rat sequences differ from the mouse sequence by 89 and 31 bases respectively, i.e. the rat sequence has more 'homology' than the human sequence with the mouse sequence. The start codon is ATG for all sequences and the 10 bases immediately preceeding this codon, CAGGAGCAGG, are also highly conserved which suggest a common ribosomal binding domain. The extended sequence CAG-GAGCAGGATG GCGGC is also similar in all sequences (see Figure 2) , and the underlined sequence should be compared with the sequence ACCATGG identified by Kozak as the optimal sequence for initiation by eukaryotic ribosomes (21) . On matching the 5-flanking sequences of the longest human, the rat and the mouse sequences with data deposited in GeneBank we found 24 entries which had 91% identity in 66 bp overlaps of 80 bps of the human sequence. Most of these identities were with ribosomal RNAs mostly from eukaryotic sources. The rat sequence showed at best 81% identities in 22 bp overlaps of 50 bps, and the mouse sequence showed at best 77.6% identities in 58 bp overlaps of 81 bps. The human 5' sequence has more "commonality" with reported human sequences than any other sequences.
The coding region
The DNA coding seqe.ence of human dihydropteridine reductase contains 9 bases (three alanine residues) more than the rat and mouse sequences which have the same number of bases (Figures 2 and 3) . The human stop codon is TAG whereas the rat and mouse use TAA. The human sequence differs from the mouse sequence by 89 bases but it differs form the rat sequence by only 31 bases out of 720 bases. The similarity between the amino acid sequences of the gene products is even more striking since a base Figure 3 . The rat sequence differs from the mouse sequence in six amino acid residues and most of them are conservative changes except for the two underlined, viz: VS3 ---7 I, D70 -~ E, M 106 ---'7 L, MI12 ---7 I, ~1 73---7~ and A222 -7~ . The last change A ---7 P is also found in the human reductase. Since proline could have a serious effect on the formation of a l3-turn, we re -checked the sequences to confirm that a proline and an alanine residue were indeed present at positions 173 and 222 respectively. The human enzyme, on the other hand, differs from the mouse enzyme in having three extra alanine residues at positions 4, 5 and 6 from the N-terminus and 15 residue changes, 5 of which are similar to those found in the rat enzyme. Most of the differences are quite conservative. These changes would not seriously alter the 3D structure of the enzyme. \Ve haye run hydrophilicity, surface probability, flexibilin· , antigenic index, amphiphilic helix, amphiphilic sheet and secondary structure plots for the three amino acid sequences using the MacVector program and found very little differences between the plots of the human and mouse sequences. The X-ray crystal structures of rat (22) and human (23) reductases expressed from cDNA in E coli have been determined and the structures are remarkably similar. The amino acid differences between the rat and the mouse enzymes (6 residues, one of which was the same as in the human sequence, see above) are concerved changes and it could be predicted that the 3D structure of the mouse enzyme should be very similar to the structures of the rat and the human enzymes. The kinetic parameters (see Table I ) reflect the similarities in structures (see below).
The 3'-flanking region
This region from the stop codon to the poly-A tail of clones 2-6 had the same length of nucleotides but clone 1 was much longer (see Figure 2) . The sequence of clone 1 was the same as those of clones 2-6 but was extended by 612 bases before the poly-A sequence. Clones 2 -6 possessed the AAT AAA sequence 16 bases upstream from the poly-A tail. This sequence is the most generally universal and characteristic eukaryotic sequence feature of RNA polymerase II genes (24, 25) . It is the anchor for the poly-A polymerase complex (25) for poly-A synthesis. This is confirmed by the AT, GT and T rich regions upstream of this sequence. This concensus sequence is present in the longer mouse clone 1 which has another AATAAA sequence 42 bases upstream of the poly-A tail. This clone therefore has two apparent poly-A polymerase signals. Multiplicity of these sequences has been observed before (25) (26) (27) (28) . The sequences between these two sites are AT, GT and T rich. The rat DNA also has the AA T AAA sequence 22 bases upstream of the poly-A tail. The 3'-flanking region of the two reported human cDNAs are almost identical except for a small number of differences which are most probably due to errors in reading. One of these (6 ) is longer than the other (5) by 265 bases. The shorter sequence has an AATAAA signal 11 bases from the poly-A tail, and the longer sequence has in fact two AATAAA sequences 11 and 149 bases upstream of the poly-A tail and the intervening sequences are as above quite rich in AT, GT and T bases. Sequences such as AA T AA, ATTA.A., ATTAAA and ATAAA (27, 29 ) can be found but sequences surrounding them do not appear to indicate that they may be other polyadenylation signals. On matching the 3' -flanking DNA sequences of the longest human, the rat and the mouse DNA sequences with data in Gene Bank, much poorer identities were found than with 5 '-flanking sequences (see above) .
Preparation and properties of mouse DHPR
The sequencing of mouse DHPR in the present study has prompted us to express the enzyme in bacteria. We have engineered a plasmid pGEX2T-mDHPR by replacing almost all the DNA sequence of the human DHPR gene in the plasmid pGEX2T-hDHPR by the mouse eDNA of clone 2 ( Figure 2 ). This was possible (see Scheme 1 ) because of the presence of the restriction enzyme sites, Asc I and EeaR I, in the appropriate D~;\ regions. The insertion of mDHPR in the ne\\· plasmid was confirmed beyond doubt by sequencing (see Matrial and Methods ). The E coli clone possessing this plasmid was used to express the fusion protein GST-mDHPR which was purified by GS-Agarose affinity chromatography and cleaved on the beads with human thrombin. The purified enzyme gave one band on SDS-PAGE with an M , value of -28 k. It runs slightly slower than human DHPR which runs at -26 k. This mouse reductase contains the complete amino acid se-quence of mouse DHPR except for the sequence very near the amino terminal which is MAAAAAAGEA (from the human sequence) instead of MAASGEA (Figure 3 ) because of the position of the Asc I restriction site in the eDNA sequence .
The subunit molecular weight observed on SDS-PAGE of this mouse reductase is M, -28 k and and also runs slower (above)than that of the human enzyme (observed on gel M, -26 k, calculated subunit molecular weight from the amino acid composition deduced from the eDNA is 25. 76 kD), although the value calculated from the amino acid sequence is 25.545 kD. Since this protein would not be completely identical with pure natural mouse dihydropteridine reductase, and because the latter had not been previously described in the literature, we decided to isolate and purify to virtual homogeneity the reductase from mouse liver. This was accomplished using procedures that were successful for purifying the reductase from human liver (16) . The pure natural enzyme behaved like the cloned protein on SDS-PAGE by displaying a band at Mr 28 k. The descrepancy observed on the SDS gels cannot be attributed to charge because charge differences do not seriously affect SDS gels and the amino acid sequences of the enzymes expressed in E coli are quite similar. The M , differences could probably be due to differences in folding. Whatever it is, the expressed and the natural mouse enzymes behave similarly. The natural enzyme was subjected to N-terminal amino acid sequencing but it could not be sequenced showing that like all mammalian dihydropteridine reductases the N-terminal amino acid is protected. Acid hydrolysis of this sample showed that it contained a considerable quantity of proteins.
We were now able to compare the kinetic parameters of the cloned and natural mouse enzymes. These values were determined for q-RS6MeDHP and natural q-6R-BH 2 and their respective NADH parameters, and are in Table 1 together with the respective values for the human reductases. The parameters for the reductase from mouse cDNA expression in E.coli and from mouse liver are of the same order of magnitude showing that the two enzymes are about equally efficient. The small differences could well be due to the N-terminal protecting group in the natural enzyme from mouse liver. The natural and cloned human enzymes showed similar very minor and perhaps non-consequential differences.
The high conserved homology in the coding sePteridincs/ Vol. 7 / No. 1 quences of the three reductases is characteristic of a "house-keeping" gene. It should be pointed out that lack of dihydropteridine reductase in humans is the cause of a lethal form of phenylketonuria named malignant hyperphenylalaninaemia due to dihydropteridine reductase deficiency (34, 35) . The rat and mouse coding sequences show fairly strong identity in homology with the human coding sequence but the 5' and 3' flanking sequences are very different showing that the non-coding regions of the human gene have diverted markedly from those of the rat and mouse genes.
